Selection of suitable drug and excipient candidates to prepare glass solutions by melt extrusion for immediate release oral formulations

Pharmaceutical Technology Europe

Volumn 14, Issue 10, 2002, Pages 27-28+31

  Forster, Angus ^a   Rades, Thomas ^a   Hempenstall, John ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTAME; BENZOIC ACID; CARBAMAZEPINE; CITRIC ACID; CORTICOSTEROID; DIAZEPAM; DRUG; ETHENZAMIDE; EXCIPIENT; FENOFIBRATE; GRISEOFULVIN; GRISPEG; INDOMETACIN; LACIDIPINE; LACTOSE; MACROGOL; MANNITOL; NABILONE; NAPROXEN; NIFEDIPINE; NITROFURANTOIN; PARACETAMOL; PHENOBARBITAL; PIROXICAM; POVIDONE; SUGAR; TEMAZEPAM; TOLBUTAMIDE; UNINDEXED DRUG; UREA; XYLITOL;

CONTROLLED RELEASE FORMULATION; COST EFFECTIVENESS ANALYSIS; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISPERSION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MEGADOSE; DRUG MIXTURE; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; EVAPORATION; GLASS TRANSITION TEMPERATURE; HYDROPHILICITY; MATERIALS TESTING; MELT EXTRUSION; MELTING POINT; MISCIBILITY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; PHYSICAL PHASE; REVIEW; SHEAR STRESS; SOLID; SOLUBILITY; SPRAY DRYING; THERMOSTABILITY;

EID: 0036794236     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. W.L. Chiou and S. Riegelman, "Pharmaceutical Applications of Solid Dispersion Systems," J. Pharm. Sci. 60, 1281-1302 (1971).
2. J.L. Ford, "The Current Status of Solid Dispersions," Pharm. Acta Hel. 61, 69-88 (1986).
3. M.J. Arias et al., "Influence of the Preparation Method of Solid Dispersions on Their Dissolution Rate - Study of Triamterene-D-Mannitol System," Int. J. Pharm. 123, 25-31 (1995).
4. R. Jachowicz and E. Nürnberg, "Enhanced Release of Oxazepam from Tablets Containing Solid Dispersions," Int. J. Pharm. 159, 149-158 (1997).
5. A.T.M. Serajuddin, "Solid Dispersion of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems and Recent Breakthroughs," J. Pharm. Sci. 88, 1058-1066 (1999).
6. C. Leuner and J. Dressman, "Improving Drug Solubility for Oral Drug Delivery Using Solid Dispersions," Eur. J. Pharm. Biopharm. 50, 47-60 (2000).
7. V.V. Boldyrev et al., "Preparation of the Dispersive Systems of Sulfathiazole-Polyvinylpyrrolidone by Mechanical Activation," Drug Dev. Ind. Pharm. 20, 1103-1114 (1994).
8. B.C. Hancock and G. Zografi, "Characteristics and Significance of the Amorphous State in Pharmaceutical Systems," J. Pharm. Sci. 86, 1-12 (1997).
9. J.W. McGinity, P. Maincent and H. Steinfink, "Crystallinity and Dissolution Rate of Tolbutamide Solid Dispersions Prepared by the Melt Method," J. Pharm. Sci. 73, 1441-1444 (1984).
10. D.Q.M. Craig et al., "The Relevance of the Amorphous State to Pharmaceutical Dosage Forms: Glassy Drugs and Freeze Dried Systems," Int. J. Pharm. 179, 179-207 (1999).
11. F. Zhang and J.W. McGinity, "Properties of Hot-Melt Extruded Theophylline Tablets Containing Poly(vinyl acetate)," Drug Dev. Ind. Pharm. 26, 931-942 (2000).
12. A. Dreiblatt and K. Eise, "Intermeshing Twin-Screw Extruders," in C. Rauwendaal, Ed., Mixing in Polymer Processing (Marcel Dekker Inc., New York, New York, USA, 1991) pp 241-266.
13. H.H. Grünhagen, "Polymer/Drug-Melt Extrusion: Therapeutic and Technological Appeal," Pharm. Technol. Eur. 11, 22-27 (1996).
14. G. Isaakides, A. Frendel and J. Bouton, "MiniLab-Compounder and Reactor," Polymer Processing Society Meeting-17, LR 43E, (2001).
15. B.C. Hancock and G. Zografi, "The Relationship Between the Glass Transition Temperature and the Water Content of Amorphous Pharmaceutical Solids," Pharm. Res. 11, 471-477 (1994).
16. M. Song et al., "Modulated Differential Scanning Calorimetry: 4. Miscibility and Glass Transition Behaviour in Poly(methylmethacrylate) and Poly(epichlorohydrin) Blends," Polymer 37, 5661-5665 (1996).
17. R. Hatley, "Glass Fragility and the Stability of Pharmaceutical Preparations - Excipient Selection," Pharm. Dev. Tech. 2, 257-264 (1997).
18. A.H. Forster et al., "The Potential of Small-Scale Fusion Experiments and the Gordon-Taylor Equation to Predict the Suitability of Drug/Polymer Blends for Melt Extrusion," Drug Dev. Ind. Pharm. 27(6), 549-560 (2001).
19. E. Fukuoka, M. Makita and S. Yamamura, "Some Physicochemical Properties of Glassy Indomethacin," Chem. Pharm. Bull. 34, 4314-4321 (1986).
20. M.A. Repka et al., "Influence of Plasticisers and Drugs on the Physical-Mechanical Properties of Hydroxypropylcellulose Films Prepared by Hot Melt Extrusion," Drug Dev. Ind. Pharm. 25, 625-633 (1999).
21. J. Breitenbach, "Feste Lösungen Durch Schmelzexrusion - Ein Integriertes Herstellkonzept," Phamazie 29, 46-49 (2000).
22. A. Forster, J. Hempenstall and T. Rades, "Selection of Excipients for Melt Extrusion with Two Poorly Water-Soluble Drugs by Solubility Parameter Calculation and Thermal Analysis," Int. J. Pharm. 226, 147-161 (2001).
23. D.W. Van Krevelen, Properties of Polymers (Elsevier, Amsterdam, The Netherlands, 1990).
24. D.L. Greenhalgh et al., "Solubility Parameters as Predictors of Miscibility in Solid Dispersions," J. Pharm. Sci. 88, 1182-1190 (1999).
25. J. Breitenbach, W. Schrof and J. Neumann, "Confocal Raman-Spectroscopy: Analytical Approach to Solid Dispersions and Mapping of Drugs," Pharm. Res. 16(7), 1109-1113 (1999).